Objective
Novel immunotherapies, such as bispecific antibodies (BiAbs), have transformed lymphoma treatment. Although biAbs are currently mostly used in later lines, their efficacy and scalability are expected to establish them as a major component of first-line treatment. However, relapse and refractory disease remain common during biAb therapy. Modes of escape are not clearly defined, comprehensive analyses of the surfaceome are lacking, and clinical biAbs are currently limited to CD3×CD20. Multispecific antibodies (msAbs) that can target more than two antigens and engage additional effector cells could overcome the limitations of current biAbs.
To this end, we will map biAb escape in patients and use these insights to guide the development of novel, optimised msAbs, with the ultimate aim of improving lymphoma therapy. In Aim 1, we will define resistance at the surfaceome level in biosamples from a longitudinal cohort by integrating molecular surfaceome profiling with mechanistic validation in ex vivo killing assays. In Aim 2, we will establish and refine an msAb pipeline to enable the rapid design, production and testing of msAbs. As an initial proof of concept, we will prioritise msAbs that engage NK cells, as this is an under-explored effector route in lymphoma. Using the resistance map from Aim 1, we will then design msAbs that specifically overcome biAb escape. In Aim 3, we will evaluate lead candidates using patient-derived organoids and humanised lymphoma mouse models, with the aim of identifying constructs for further development. My group and I are well placed to fulfil all aims and lead the project to success, leveraging our extensive experience in clinical haematology and in-depth knowledge of human antibody engineering.
In conclusion, our project will improve understanding of biAb resistance and escape and deliver novel, optimised msAbs that are highly effective, limit escape and have favourable safety profiles, thereby significantly advancing lymphoma therapy.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine hematology
- medical and health sciences basic medicine immunology immunotherapy
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.1 - European Research Council (ERC)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-ERC - HORIZON ERC Grants
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) ERC-2026-STG
See all projects funded under this callHost institution
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
50937 Koeln
Germany
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.